James R. Tobin - Aug 8, 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Director
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Aug 8, 2024
Transactions value $: -$3,186,536
Form type: 4
Date filed: 8/9/2024, 04:30 PM
Previous filing: Jun 14, 2024
Next filing: Sep 17, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Sale	-$2.01M	-12.7K	-6.56%	$158.96	180K	Aug 8, 2024	By the James R. Tobin 2012 Trust	F1
transaction	TMDX	Common Stock	Sale	-$1.17M	-7.34K	-4.06%	$159.96	173K	Aug 8, 2024	By the James R. Tobin 2012 Trust	F2
holding	TMDX	Common Stock						1.93K	Aug 8, 2024	Direct

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $158.75 to $159.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $159.77 to $160.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.